Page last updated: 2024-12-05

hentriacontane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Hentriacontane is a straight-chain alkane with the formula C31H64. It is a white, waxy solid that is found in a variety of natural sources, including plants, animals, and petroleum. Hentriacontane is an important component of waxes, which are used in a variety of applications, such as candles, cosmetics, and lubricants. It is also studied for its potential applications in the development of new materials, such as biodegradable plastics. Hentriacontane can be synthesized through a variety of methods, including the Fischer-Tropsch process, which involves the reaction of carbon monoxide and hydrogen. It has also been found in various organisms, including bacteria, yeast, and plants, highlighting its natural prevalence. Hentriacontane is generally considered non-toxic and safe for human use, but it is important to note that its specific effects may vary depending on the individual and the route of exposure.'

Cross-References

ID SourceID
PubMed CID12410
CHEMBL ID257490
CHEBI ID5659
MeSH IDM0141083

Synonyms (27)

Synonym
LS-15322
AKOS015843210
n-hentriacontane
hentriacontan
CHEBI:5659 ,
ch3-[ch2]29-ch3
hentriacontane
C08376
630-04-6
untriacontane
441529E2-C629-4003-A2DD-9134C4C1801B
CHEMBL257490
H0012
LMFA11000573
unii-6sdg640hl3
6sdg640hl3 ,
hsdb 8361
n-hentriacontanone
DTXSID0075443
mfcd00048745
hentriacontane, analytical standard
hentriacontane; untriacontane; n-hentriacontane
FT-0711394
n-hentriacontane 100 microg/ml in hexane
Q151082
STL564734
T72739
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antitubercular agentA substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
long-chain alkaneAny alkane having a chain length of at least 13 carbon atoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID315606Growth inhibition of human BGC823 cells at 5 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID399674Diuretic activity in rat at 125 mg/kg
AID399675Antiinflammatory activity against carrageenan-induced hind paw edema in rat at 100 mg/kg
AID315607Growth inhibition of human BGC823 cells at 10 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID315608Growth inhibition of human BGC823 cells at 50 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID315609Growth inhibition of human BGC823 cells at 100 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.67)18.7374
1990's1 (6.67)18.2507
2000's5 (33.33)29.6817
2010's8 (53.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.87 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index48.16 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]